User profiles for N. Kandiah
 | Nagaendran KandiahProfessor of Neuroscience Verified email at ntu.edu.sg Cited by 5147 |
Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's …
… =152) on the prevalence of wild-type BuChE genotype showed that most of the patients (n=…
ε4 carriers (n=246) and declined ADAS-cog by 0.48 points in the APOE ε4 noncarriers (n=121…
ε4 carriers (n=246) and declined ADAS-cog by 0.48 points in the APOE ε4 noncarriers (n=121…
Therapeutic potential of statins in Alzheimer's disease
N Kandiah, HH Feldman - Journal of the neurological sciences, 2009 - Elsevier
There is increasing evidence linking cholesterol metabolism with the neurofibrillary pathology
of Alzheimer's disease (AD). Cholesterol and its transport have been shown to be involved …
of Alzheimer's disease (AD). Cholesterol and its transport have been shown to be involved …
Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®
… World Federation of Societies of Biological Psychiatry guidelines list EGb 761 ® with the
same strength of evidence as acetylcholinesterase inhibitors and N‐methyl‐D‐aspartate (NMDA…
same strength of evidence as acetylcholinesterase inhibitors and N‐methyl‐D‐aspartate (NMDA…
Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study
Introduction Progress in understanding and management of vascular cognitive impairment (VCI)
has been hampered by lack of consensus on diagnosis, reflecting the use of multiple …
has been hampered by lack of consensus on diagnosis, reflecting the use of multiple …
The vascular impairment of cognition classification consensus study
Introduction Numerous diagnostic criteria have tried to tackle the variability in clinical
manifestations and problematic diagnosis of vascular cognitive impairment (VCI) but none have …
manifestations and problematic diagnosis of vascular cognitive impairment (VCI) but none have …
[HTML][HTML] Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies
Background Cerebral microbleeds are a neuroimaging biomarker of stroke risk. A crucial
clinical question is whether cerebral microbleeds indicate patients with recent ischaemic stroke …
clinical question is whether cerebral microbleeds indicate patients with recent ischaemic stroke …
Profile of and risk factors for poststroke cognitive impairment in diverse ethnoregional groups
Objective To address the variability in prevalence estimates and inconsistencies in potential
risk factors for poststroke cognitive impairment (PSCI) using a standardized approach and …
risk factors for poststroke cognitive impairment (PSCI) using a standardized approach and …
[HTML][HTML] A controlled study of team-based learning for undergraduate clinical neurology education
Background Team-based learning (TBL), a new active learning method, has not been reported
for neurology education. We aimed to determine if TBL was more effective than passive …
for neurology education. We aimed to determine if TBL was more effective than passive …
Hippocampal volume and white matter disease in the prediction of dementia in Parkinson's disease
Background Longitudinal neuroimaging studies could provide insights into pathophysiology
of cognitive impairment in PD. We examined the role of hippocampal atrophy and cerebral …
of cognitive impairment in PD. We examined the role of hippocampal atrophy and cerebral …
Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease
N Kandiah, A Zhang, AR Cenina, WL Au… - Parkinsonism & related …, 2014 - Elsevier
… Nagaendran Kandiah has received honorarium and CME sponsorship from Lundbeck,
Novartis, Pfeizer and Eisai. He has also received research funding from Singhealth Foundation, …
Novartis, Pfeizer and Eisai. He has also received research funding from Singhealth Foundation, …